Key terms

About APLT

Applied Therapeutics, Inc. is a clinical-stage biopharmaceutical company which engages in the development of a pipeline of novel products. It is targeting treatments for central nervous system rare diseases and diabetic complications. The company was founded by Shoshana Shendelman on January 20, 2016 and is headquartered in New York, NY.

Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
     
52-week range
     
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date

Key terms

Smart score

Latest APLT news

Apr 15 5:12pm ET Applied Therapeutics Welcomes Dale Hooks as New CCO by TipRanks Apr 15 7:05am ET Applied Therapeutics appoints Dale Hooks as CCO by TipRanks Apr 14 2:36am ET RBC Capital Sticks to Their Buy Rating for Applied Therapeutics (APLT) by TipRanks Apr 04 7:21am ET Applied Therapeutics to present data from study of caficrestat in DbCM by TipRanks Apr 03 2:01am ET Analysts Offer Insights on Healthcare Companies: Disc Medicine (IRON), Applied Therapeutics (APLT) and Vincerx Pharma Inc (VINC) by TipRanks Mar 28 4:54pm ET Applied Therapeutics down 11% after extended FDA review for govorestat NDA by TipRanks Mar 28 4:34pm ET Applied Therapeutics: FDA extends review period for NDA for govorestat by TipRanks Mar 25 4:08pm ET Applied Therapeutics initiated with an Outperform at RBC Capital by TipRanks Mar 22 4:33pm ET Applied Therapeutics files to sell 14.29M shares of common stock for holders by TipRanks Mar 20 8:46am ET Largest borrow rate increases among liquid names by TipRanks Mar 13 2:20am ET Wall Street Analysts Are Bullish on Top Healthcare Picks by TipRanks Mar 11 8:32am ET Applied Therapeutics Reveals Strategy and Positive Trial Update by TipRanks Mar 11 12:40am ET Analysts Offer Insights on Healthcare Companies: Applied Therapeutics (APLT), Xeris Pharmaceuticals (XERS) and Arcturus Therapeutics (ARCT) by TipRanks Mar 08 1:02am ET Applied Therapeutics’ New Accounting & Financial Operations Risk – A Cause for Worry? by TipRanks Mar 06 7:49am ET Applied Therapeutics price target raised to $12 from $4 at UBS by TipRanks Mar 06 7:08am ET Applied Therapeutics reports FY23 EPS ($1.42), consensus ($1.42) by TipRanks Mar 01 1:19am ET Optimistic Buy Rating for Applied Therapeutics Amid Favorable Drug Approval Prospects and Strong Financial Position by TipRanks Mar 01 1:05am ET Buy Rating Affirmed for Applied Therapeutics as FDA Prioritizes Govorestat, Signaling Strong Market Prospects by TipRanks Feb 28 8:17am ET Applied Therapeutics to sell 12.3M shares at $7.00 in private placement by TipRanks Feb 28 8:05am ET Applied Therapeutics receives FDA acceptance, Priority Review for govorestat NDA by TipRanks Feb 22 6:17am ET Applied Therapeutics initiated with an Outperform at Leerink by TipRanks Feb 16 7:24am ET Analyst Upgrades Applied Therapeutics Target to $7 on SORD Program Progress and Govorestat Pricing Reassessment by TipRanks Feb 16 6:57am ET Applied Therapeutics price target raised to $7 from $5 at Citi by TipRanks Feb 15 7:22am ET Applied Therapeutics’ Govorestat Shows Promise in Phase 3 Trial by TipRanks Feb 15 7:14am ET Applied Therapeutics announces results from 12-month interim analysis of AT-007 by TipRanks

No recent press releases are available for APLT

APLT Financials

1-year income & revenue

Key terms

APLT Forecasts

analyst rating

  • buy
  • hold
  • sell

We're sorry, but this
information is
temporarily unavailable.

1-year stock price forecast

APLT Competitors

$ Market cap P/E ratio $ Price 1d change 52-week range

Key terms

Latest investing news

Trump Media, which runs the social media platform Truth Social, took the place of Digital World's place on the Nasdaq stock exchange in March.
Frank Franklin II/AP
Trump Media stock ends session 15% higher after two very bad days
Students at Highlands High School, work on a practice test at the ACT Boot Camp in Newport, Ky.
Patrick Reddy/The Enquirer/AP/File
Private equity finds its next bet: college admissions
In this photo illustration, Republican presidential candidate former President Donald Trump's social media platform Truth Social is shown on a cell phone on March 25, 2024 in Chicago, Illinois.
Scott Olson/Getty Images
Trump’s stock tumbles again after Truth Social announces it’s getting into streaming
Tim Wren, chief commercial officer for BSI Group, right, presents Kristalina Georgieva, chief executive officer of the World Bank Group, second right, with ISO 20121 certification for sustainable event management at an event during the spring meetings of the International Monetary Fund (IMF) and World Bank in Washington, DC, US, on Monday, April 15, 2024. The IMF and World Bank spring meetings in Washington are expected to draw thousands of delegates, observers and journalists from the fund's 190 member countries. Photographer: Samuel Corum/Bloomberg via Getty Images
Samuel Corum/Bloomberg/Getty Images
Geopolitical strife is roiling Wall Street. Here’s what investors are watching